EQR
59
5
CMI
64
5
SO
57
2
GPC
37
2
CFG
64
2
DHR
38
3
PPG
60
3
ROST
52
5
PWR
72
2
WDC
43
2
WHR
64
3
SYK
68
4
PPL
59
5
GIS
28
2
O
22
2
SWK
61
5
ORLY
60
7
AVB
64
4
MRK
27
5
MRO
40
-15
EQR
59
5
CMI
64
5
SO
57
2
GPC
37
2
CFG
64
2
DHR
38
3
PPG
60
3
ROST
52
5
PWR
72
2
WDC
43
2
WHR
64
3
SYK
68
4
PPL
59
5
GIS
28
2
O
22
2
SWK
61
5
ORLY
60
7
AVB
64
4
MRK
27
5
MRO
40
-15
Financhill
Back

Akari Therapeutics PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison

Sell
10

AKTX
Akari Therapeutics PLC

Last Price:
1.28
Seasonality Move:
-8.33%
Sell
20

ADAP
Adaptimmune Therapeutics PLC

Last Price:
0.63
Seasonality Move:
50.57%
Sell
10
Akari Therapeutics PLC (AKTX) is a Sell

Is Akari Therapeutics PLC a Buy, Sell or Hold?

  • The current Akari Therapeutics PLC [AKTX] share price is $1.24. The Score for AKTX is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • AKTX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
20
Adaptimmune Therapeutics PLC (ADAP) is a Sell

Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?

  • The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.64. The Score for ADAP is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • ADAP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

AKTX Stock Price Chart

What is Akari Therapeutics PLC's stock price today?

  • The Akari Therapeutics PLC share price today is $1.24
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKTX is experiencing slight selling pressure.

ADAP Stock Price Chart

What is Adaptimmune Therapeutics PLC's stock price today?

  • The Adaptimmune Therapeutics PLC share price today is $0.64
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing selling pressure, which indicates risk of future bearish movement.

AKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 24.41 Sell
Chaikin Money Flow: -35482 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.9 - 2.56) Sell
Bollinger Bands (100): (2.47 - 3.73) Sell

ADAP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 36.24 Sell
Chaikin Money Flow: -608296 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.66 - 0.82) Sell
Bollinger Bands (100): (0.81 - 1.21) Sell

AKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.93 Sell
20-day SMA: 2.23 Sell
50-day SMA: 2.61 Sell
200-day SMA: 2.54 Sell
8-day EMA: 1.81 Sell
20-day EMA: 2.13 Sell
50-day EMA: 2.52 Sell
200-day EMA: 2.93 Sell

ADAP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.66 Sell
20-day SMA: 0.73 Sell
50-day SMA: 0.85 Sell
200-day SMA: 1.12 Sell
8-day EMA: 0.67 Sell
20-day EMA: 0.73 Sell
50-day EMA: 0.83 Sell
200-day EMA: 1 Sell

Akari Therapeutics PLC Earnings Growth & AKTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and a decrease next year of $0.00 per share.

Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.33 per share.

Akari Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Adaptimmune Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):